Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: Role of nitric oxide and ATP-sensitive potassium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 655-664

  Hein, Travis W ^a   Belardinelli, Luiz ^b   Kuo, Lih ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b CV THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; NITRIC OXIDE; POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL TONE; ENDOTHELIUM; FEMALE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; VASODILATATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CAPILLARIES; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYBURIDE; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENETHYLAMINES; POTASSIUM CHANNELS; RECEPTORS, PURINERGIC P1; SWINE; VASODILATOR AGENTS;

EID: 0032695630     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Abebe W, Hussain T, Olanrewaju H and Mustafa SJ (1995) Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am J Physiol 269:H1672-H1678.
2. Abebe W, Makujina S and Mustafa SJ (1994) Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am J Physiol 35:H2018-H2025.
3. 2 receptor mediated coronary vasodilation in the dog. Cardiovasc Res 28:906-911.
4. 2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells. Br J Pharmacol 119:1286-1290.
5. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
6. 2+ measured with fura-2. Br J Pharmacol 104:373-378.
7. 2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284:1066-1073.
8. Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807-813.
9. 3H]NECA in rat striatal membranes. Mol Pharmacol 29:331-346.
10. 2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. Br J Pharmacol 122:546-550.
11. Dart C and Standen NB (1993) Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J Physiol 471:767-786.
12. 1 receptor-mediated responses in rat hippocampus. J Neurosci 17:607-614.
13. Falloon BJ, Stephens N, Tulip JR and Heagerty AM (1995) Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol 268:H670-H678.
14. 2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart. Eur J Pharmacol 263:261-268.
15. 2b adenosine subtypes. Biochem Pharmacol 55:627-633.
16. Foulkes R, Shaw N, Bose C and Hughes B (1991) Differential vasodilator profile of calcitonin gene-related peptide in porcine large and small coronary artery rings. Eur J Pharmacol 201:143-149.
17. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P and Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
18. 3-selective adenosine agonists. J Med Chem 37:636-646.
19. Habazettl H, Conzen PF, Vollmar B, Baier H, Christ M, Goetz AE, Peter K and Brendel W (1992) Dilation of coronary microvessels by adenosine induced hypotension in dogs. Int J Microcirc Clin Exp 11:51-65.
20. Hein TW and Kuo L (1998) LDLs impair vasomotor function of the coronary microcirculation: Role of superoxide anions. Circ Res 83:404-414.
21. Herlihy JT, Bockman EL, Berne RM and Rubio R (1976) Adenosine relaxation of isolated vascular smooth muscle. Am J Physiol 230:1239-1243.
22. Ishizaka H and Kuo L (1996) Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle. Circ Res 78:50-57.
23. 3 adenosine receptor-selective antagonists. Neuropharmacology 36:1157-1165.
24. Jacobson KA and van Rhee AM (1997b) Development of selective purinoceptor agonists and antagonists, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 101-128, Wiley-Liss, New York.
25. Jiang C, Poole-Wilson P and Collins P (1991) Comparison of rabbit coronary arterial relaxation induced by acetylcholine and lemakalim: Activation of ATP sensitive potassium channels. Cardiovasc Res 25:930-935.
26. 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 87:1264-1274.
27. Jones CJH, Kuo L, Davis MJ and Chilian WM (1995a) Regulation of coronary blood flow: Coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 29:585-589.
28. Jones CJH, Kuo L, Davis MJ, DeFily DV and Chilian WM (1995b) Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 91:1807-1813.
29. King AD, Milavec-Krizman M and Muller-Schweinitzer E (1990) Characterization of the adenosine receptor in porcine coronary arteries. Br J Pharmacol 100:483-486.
30. Klotz K-N, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB and Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch Pharmacol 357:1-9.
31. ATP channels in endothelium. Am J Physiol 269:H541-H549.
32. Kuo L, Chilian WM and Davis MJ (1991) Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 261:H1706-H1715.
33. Kuo L, Davis MJ and Chilian WM (1988) Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am J Physiol 255:H1558-H1562.
34. Li J-M, Fenton RA, Cutler BS and Dobson JG Jr (1995) Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol 269:C519-C523.
35. Liao JC and Kuo L (1997) Interaction between adenosine and flow-induced dilation in coronary microvascular network. Am J Physiol 272:H1571-H1581.
36. ATP channel involvement in adenosine receptor-mediated dilation of epicardial vessels. Am J Physiol 267:H716-H724.
37. 2a receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286:1051-1057.
38. 2 adenosine receptor activity. Biochem Biophys Res Commun 168:1297-1302.
39. ATP channels. Am J Physiol 273:H2687-H2695.
40. Müller CE and Stein B (1996) Adenosine receptor antagonists: Structures and potential therapeutic applications. Curr Pharm Design 2:501-530.
41. 2α-induced contractions of cat isolated arteries. Eur J Pharmacol 191:359-368.
42. + channel activation. Am J Physiol 265: H1289-H1293.
43. 2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats. Eur J Pharmacol 307:163-169.
44. Niiya K, Uchida S, Tsuji T and Olsson RA (1994) Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists. J Pharmacol Exp Ther 271:14-19.
45. Olsen KM, Kearns GL and Kemp SF (1995) Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes. J Clin Pharmacol 35:739-745.
46. Pohl U, Lamontagne D, Bassenge E and Busse R (1994) Attenuation of coronary autoregulation in the isolated rabbit heart by endothelium derived nitric oxide. Cardiovasc Res 28:414-419.
47. 2a selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102.
48. Randall MD (1995) The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart. Br J Pharmacol 116:3068-3074.
49. Rosenblum WI and Nelson GH (1990) Tone regulates opposing endothelium-dependent and -independent forces: Resistance brain vessels in vivo. Am J Physiol 259:H243-H247.
50. Rubanyi G and Vanhoutte PM (1985) Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 7:139-144.
51. Saito Y, Eraslan A and Hester RL (1994) Role of endothelium-derived relaxing factors in arteriolar dilation during muscle contraction elicited by electrical field stimulation. Microcirculation 1:195-201.
52. 125I]AB-MECA) labels multiple adenosine receptor subtypes in rat brain. Brain Res 746:10-20.
53. 2A-adenosine receptor reserve for coronary vasodilation. Circulation 98:711-718.
54. 2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: A role for nitric oxide. Br J Pharmacol 109:424-429.
55. White TD and Angus JA (1987) Relaxant effects of ATP and adenosine on canine large and small coronary arteries in vitro. Eur J Pharmacol 143:119-126.
56. 2a adenosine receptor antagonist. J Pharmacol Exp Ther 276:398-404.